Wockhardt Ltd

Type: Company
Name: Wockhardt Ltd
Nationality: India
Fact Sheet: Fact Sheet for Wockhardt Ltd.
First reported 9 hours ago - Updated 9 hours ago - 1 reports

US Congress steps up pressure for action on Sun Pharma, DRL

The US legislature's probe into ''abnormal'' increases in drug prices by 14 pharmaceutical companies, including India's Fceutical Industries and Dr Reddy's Laboratories, has gone to the next level.Congress (the legislature) has written to US health secretary ... [Published Smart Investor - 9 hours ago]
First reported Oct 16 2014 - Updated Oct 17 2014 - 1 reports

Pharma stocks edge higher on weak rupee

Eight pharma stocks rose by 0.01% to 1.4% at 12:45 IST on BSE as rupee edged lower against the dollar.Meanwhile, the BSE Sensex was up 12.16 points, or 0.09%, to 26,372.02.Among pharma stocks, Cipla (up 0.64%), Lupin (up 0.25%), Dr Reddy's Laboratories ... [Published Business Standard India - Oct 16 2014]
First reported Oct 12 2014 - Updated Oct 12 2014 - 1 reports

Less competition, demand-supply gap push US drug prices

Even as the US legislature has initiated a probe against several leading generic drug makers, including three Indian companies, for the extent of price increases, industry officials say several factors have led to the significant increase in prices of ... [Published Business Standard India - Oct 12 2014]
First reported Oct 09 2014 - Updated Oct 09 2014 - 1 reports

3 Indian pharma firms named in US Congress price probe

Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months Ambit: The Congressional investigation seeks information like total gross revenue of the companies concerned from sale of the drugs in questionFiner details: The probe ... [Published rediff.com - Oct 09 2014]
First reported Oct 05 2014 - Updated Oct 05 2014 - 1 reports

Pharma may be a not-so-sweet play in the short term

If you thought the export-oriented pharma sector was a promising defensive sector, think again. While the bulk of pharma stocks has enjoyed a secular rally in the past five years, abrupt developments like US FDA import alerts, price controls by the regulatory ... [Published Economic Times - Oct 05 2014]
First reported Oct 01 2014 - Updated Oct 02 2014 - 1 reports

WOCKHARDT : Various events to mark World Heart Day

Nagpur : To mark World Heart Day on Sunday different hospitals are organizing awareness programmes for citizens, especially women and children. Wockhardt hospitals will be conducting an educative and interactive campaign. Three heart shaped mascots by ... [Published 4 Traders - Oct 01 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

Wockhardt announces change in directorate

Wockhardt announced that R. A. Shah, the Non Executive Independent Director of the Company has relinquished directorship of the Company with effect from 30 September 2014, in view of the imminent regulatory changes.Further the Company has informed that, ... [Published HDFC Securities - Oct 01 2014]
First reported Oct 01 2014 - Updated Oct 01 2014 - 1 reports

5 Pharma stocks that propelled BSE Healthcare to lifetime high

MUMBAI: The BSE Healthcare Index is at fresh all-time high today even as valuations of some companies in the index looks a little stretched. Investors came back to the sector after the Q1 results of sectors such as infrastructure, metals and PSU banks ... [Published Economic Times - Oct 01 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Top 100 Richest Indians: India's Pharma Sector Mints Billionaires

Pharma is on a roll. More than a fifth of the 100 richest billionaires in India have pharma and health care riches, among them half of the eight newcomers, such as Hasmukh Chudgar , whose Intas Pharmaceuticals was recently valued by Temasek at close to ... [Published Forbes.com - Sep 25 2014]
Entities: Mints, Pharmaceutical, India
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

Jugaad is a valid concept for India society, says Wockhardt's MD Murtuza Khorakiwala

In 2009, Habil Khorakiwala, Wockhardt's chairman and managing director, let go of the title of 'MD' from his designation to make room for the younger generation in the top management. It was, however, not the best time in the drug manufacturing company's ... [Published Economic Times - Sep 25 2014]
First reported Sep 23 2014 - Updated Sep 23 2014 - 1 reports

Go long in Wockhardt, says Rahul Mohindar

"I would reckon buying it past Rs 830 which would be a good idea with Rs 790 being a stoploss and one should go long and the targets on it would be a new high to about Rs 920. There has been a good volume action too on the stocks and there could be good ... [Published Moneycontrol.com - Sep 23 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Wockhardt’s two anti-infective drugs get QIDP status from US FDA

WCK 771 is an intravenous (IV) drug while WCK 2349 is a solid oral tabletWockhardt's New Drug Discovery programme in anti-infective research received a major boost after two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious ... [Published Express Pharma - Sep 22 2014]

Quotes

Adding: "We believe the federal government must act immediately and aggressively to address the increasing cost of drugs. With that goal in mind, we ask that you provide to our offices, analysis of the national average drug acquisition cost data maintained by the Centres for Medicare and Medicaid Services that our staff has requested, so we can understand the price increase trends."
"U SS Pat. Nos. 5,145,684; 6,375,986; 6,969,529; and 6,592,903 disclose nanoparticulate compositions of fenofibrate."

More Content

All (175) | News (163) | Reports (0) | Blogs (9) | Audio/Video (0) | Fact Sheets (3) | Press Releases (0)
sort by: Date | Relevance
US Congress steps up pressure for action on Sun... [Published Smart Investor - 9 hours ago]
DLF jumps after filing appeal against Sebi deci... [Published Business Standard India - 14 hours ago]
4th straight week of losses for Sensex, Nifty [Published India Infoline - Oct 17 2014]
Indian stock market daily morning report (Octob... [Published Stock Markets Review - Oct 17 2014]
Pharma stocks edge higher on weak rupee [Published Business Standard India - Oct 16 2014]
Patent Issued for Pharmaceutical Compositions o... [Published 4 Traders - Oct 16 2014]
4 things to know about India’s next crown jewel... [Published Forbes India - Oct 16 2014]
Patent Issued for Nitrogen Containing Compounds [Published 4 Traders - Oct 16 2014]
Gujarat CM to open Rs. 450 crore plant of Abbot... [Published DeshGujarat - Oct 15 2014]
Abbott Nutrition to open its largest import sub... [Published Livemint.com - Oct 15 2014]
Cadaver liver ‘wasted’ due to red-tape delay [Published Pune Mirror - Oct 13 2014]
India's leading animal health companies: Good p... [Published Animal Pharm News - Oct 13 2014]
Nifty scales past 7,900 as Street sees smart re... [Published Economic Times - Oct 13 2014]
Smart recovery on D-Street; Nifty near 7,850; t... [Published Economic Times - Oct 13 2014]
Sensex recovers lost ground; top 20 intraday bets [Published Economic Times - Oct 13 2014]
Less competition, demand-supply gap push US dru... [Published Business Standard India - Oct 12 2014]
Sun rapped for lax in follow-up of recalled drugs [Published Economic Times - Oct 11 2014]
3 Indian pharma firms named in US Congress pric... [Published rediff.com - Oct 09 2014]
Seminar on research papers [Published Goa Herald - Oct 09 2014]
Patent Issued for Controlled Release Compositio... [Published 4 Traders - Oct 08 2014]
US Congress names 3 Indian firms in probe again... [Published Business Standard India - Oct 08 2014]
Ten years later, Indian hiring cos catch VC eye... [Published Economic Times - Oct 08 2014]
Companies leaving forex exposure without hedgin... [Published Economic Times - Oct 08 2014]
Sensex, Nifty hit almost eight-week closing low [Published Business Standard India - Oct 07 2014]
Sensex ends nearly 300 pts down [Published Sify - Oct 07 2014]
Drug recalls due to dissolution failures: What ... [Published Express Pharma - Oct 06 2014]
Pharma may be a not-so-sweet play in the short ... [Published Economic Times - Oct 05 2014]
All’s well@work [Published Pune Mirror - Oct 04 2014]
FCCBs return with stronger rupee, rising markets [Published Business Standard India - Oct 04 2014]
Hospital Injectable Drugs Market - Global Indus... [Published SBWire - Oct 03 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
FDA grants QIDP status for Wockhardt anti-infec... [Published PBR - News - Sep 01 2014]
Wockhardt Limited has announced a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease Product (QIDP) status from U.S. Food & Drug Administration ...
U.S. FDA Grants QIDP Status for Wockhardt Anti-... [Published PR Newswire: Health - Sep 01 2014]
PARSIPPANY, N.J., Aug. 31, 2014 /PRNewswire/ -- Wockhardt Limited today announces a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease ...
CEFTRIAXONE Injection, Powder, For Solution CEF... [Published DailyMed Drug Label Updates for the last seven ... - Aug 20 2014]
Updated Date: Aug 19, 2014 EST ...
BDA Named M&A Advisor of the Year at the 2014 A... [Published PR.com Press Releases - Jun 21 2014]
New York, NY, June 21, 2014 --( PR.com )-- Business Development Asia LLC (“BDA”) was named M&A Advisor of the Year at the ACG Champion’s Awards, held on June 19th in New York. ACG New York is the leading association for middle market dealmaking professionals: ...
What Did the FDA Find at the Wockhardt Plant? L... [Published WSJ.com: India Real Time - Jun 04 2014]
A recent FDA inspection of a key U.S. plant run by Wockhardt, an Indian drug maker that is a large supplier to the U.S., found a dozen quality-control problems and is likely to further underscore regulatory concerns about the Indian pharmaceutical industry's ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.